Idiopathic Pulmonary Fibrosis
Concept
Vocabulary Service
Overview
subject area of
-
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease Academic Article
-
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Academic Article
-
A novel profibrotic mechanism mediated by TGFβ-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells Academic Article
-
A sudden deterioration in idiopathic pulmonary fibrosis Academic Article
-
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report Academic Article
-
Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation Academic Article
-
Acute exacerbations of idiopathic pulmonary fibrosis: tough to define; tougher to manage Academic Article
-
Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis Academic Article
-
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline Academic Article
-
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management Academic Article
-
Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: the forgotten cell in COVID-19 Academic Article
-
Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone Academic Article
-
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis Academic Article
-
Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers? Academic Article
-
Antifibrotic Role of αB-Crystallin Inhibition in Pleural and Subpleural Fibrosis Academic Article
-
Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis Academic Article
-
B Cells Are Not Involved in the Regulation of Adenoviral TGF-β1– or Bleomycin-Induced Lung Fibrosis in Mice Academic Article
-
Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis Conference Paper
-
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis Academic Article
-
Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis Academic Article
-
Clinical relevance of rheumatoid factor and anti‐citrullinated peptides in fibrotic interstitial lung disease Academic Article
-
Connective-Tissue Growth Factor Contributes to TGF-β1–induced Lung Fibrosis Academic Article
-
Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease Academic Article
-
Current models of pulmonary fibrosis for future drug discovery efforts Academic Article
-
Design of the INPULSIS™ trials: Two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis Academic Article
-
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis Academic Article
-
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study Academic Article
-
Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study Academic Article
-
Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis Academic Article
-
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis Academic Article
-
Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis Academic Article
-
Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications Academic Article
-
Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada Academic Article
-
Essential Role of Osteopontin in Smoking-Related Interstitial Lung Diseases Academic Article
-
Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases Academic Article
-
FGF19 Is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits Lung Fibrosis in Mice Academic Article
-
FK506-Binding Protein 13 Expression Is Upregulated in Interstitial Lung Disease and Correlated with Clinical Severity. A Potentially Protective Role Academic Article
-
First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value Academic Article
-
Heat shock protein: a hot topic in idiopathic pulmonary fibrosis Academic Article
-
High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study Academic Article
-
Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production Academic Article
-
Identification of periplakin as a major regulator of lung injury and repair in mice Academic Article
-
Idiopathic Pulmonary Fibrosis: From Epithelial Injury to Biomarkers - Insights from the Bench Side Academic Article
-
Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name? Academic Article
-
Idiopathic pulmonary fibrosis – clinical management guided by the evidence-based GRADE approach: what arguments can be made against transparency in guideline development? Academic Article
-
Idiopathic pulmonary fibrosis: idiopathic no more? Academic Article
-
Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis Academic Article
-
Impact of Concomitant Medication Burden on Tolerability of Disease-targeted Therapy and Survival in Interstitial Lung Disease Academic Article
-
Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis Academic Article
-
Inflammation and dysregulated fibroblast proliferation--new mechanisms? Academic Article
-
Inhalation: A means to explore and optimize nintedanib's pharmacokinetic/pharmacodynamic relationship Academic Article
-
Intedanib, a triple kinase inhibitor of VEGFR, FGFR and PDGFR for the treatment of cancer and idiopathic pulmonary fibrosis. Academic Article
-
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective Academic Article
-
Lung cancer in pulmonary fibrosis: no room for nihilism! Academic Article
-
Lysyl Oxidase–Like 1 Protein Deficiency Protects Mice from Adenoviral Transforming Growth Factor-β1–induced Pulmonary Fibrosis Academic Article
-
Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertension Academic Article
-
Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis? Academic Article
-
Matrix abnormalities in pulmonary fibrosis Academic Article
-
Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysis Academic Article
-
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis Academic Article
-
Molecular breath analysis for IPF: Can we make a few breaths count? Academic Article
-
Molecular classification of idiopathic pulmonary fibrosis: Personalized medicine, genetics and biomarkers Academic Article
-
Mucking around in the Genome: MUC5B in Idiopathic Pulmonary Fibrosis Academic Article
-
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease Academic Article
-
New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational research Academic Article
-
Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis and Right Heart Dysfunction. A Prespecified Subgroup Analysis of a Double-Blind Randomized Clinical Trial (INSTAGE) Academic Article
-
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases Academic Article
-
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases Academic Article
-
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume Academic Article
-
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial Academic Article
-
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial Academic Article
-
Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis Academic Article
-
Outcomes following decline in forced vital capacity in patients with idiopathic pulmonary fibrosis: Results from the INPULSIS and INPULSIS-ON trials of nintedanib Academic Article
-
Pathways to Precision Medicine in Idiopathic Pulmonary Fibrosis. Time to Relax? Academic Article
-
Patient Characteristics and Survival for Progressive Pulmonary Fibrosis Using Different Definitions Academic Article
-
Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis Academic Article
-
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial) Academic Article
-
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis Academic Article
-
Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases Academic Article
-
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung Disease Academic Article
-
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry Academic Article
-
Prognostic impact of typical and probable usual interstitial pneumonia pattern in idiopathic pulmonary fibrosis: is the debate about biopsy a Star Wars saga? Academic Article
-
Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis Academic Article
-
R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life Academic Article
-
Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3 Academic Article
-
Regulatory T Cells Limit Pneumococcus-Induced Exacerbation of Lung Fibrosis in Mice Academic Article
-
Repeat bronchoalveolar lavage in idiopathic pulmonary fibrosis: proceed with caution? Academic Article
-
Reply to “An Important Step Forward, but Still a Way to Go” and “Idiopathic Pulmonary Fibrosis and Prothrombotic State” Academic Article
-
Reply: Can Bisphosphonates Prevent Vitamin K Antagonist Toxicity in Patients with Idiopathic Pulmonary Fibrosis? Academic Article
-
Reply: Can Warfarin Be Used in the Treatment of Pulmonary Embolism in Idiopathic Pulmonary Fibrosis? Academic Article
-
Role of matrix metalloprotease-2 and MMP-9 in experimental lung fibrosis in mice Academic Article
-
Sildenafil for idiopathic pulmonary fibrosis: A systematic review and meta-analysis Academic Article
-
Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis Academic Article
-
Staging of idiopathic pulmonary fibrosis: past, present and future Academic Article
-
Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis Academic Article
-
Study the past to divine the future. Confucius' wisdom doesn't work for idiopathic pulmonary fibrosis Academic Article
-
Synergistic role of HSP90α and HSP90β to promote myofibroblast persistence in lung fibrosis Academic Article
-
TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling Academic Article
-
The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD Academic Article
-
The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis Academic Article
-
The importance of interventional timing in the bleomycin model of pulmonary fibrosis Academic Article
-
The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy? Academic Article
-
The justification for the progressive fibrotic phenotype Academic Article
-
The natural history of progressive fibrosing interstitial lung diseases Academic Article
-
The small heat-shock protein α
B-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis Academic Article
-
Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials Academic Article
-
Therapeutic targets and early stage clinical trials for pulmonary fibrosis Academic Article
-
Therapeutic targets in idiopathic pulmonary fibrosis Academic Article
-
Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease Academic Article
-
Treating IPF-all or nothing? A PRO-CON debate Academic Article
-
Treatment of idiopathic pulmonary fibrosis with Nintedanib: an update Academic Article
-
Treatment of idiopathic pulmonary fibrosis: a network meta-analysis Academic Article
-
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis Academic Article
-
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns Academic Article
-
VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats Academic Article
-
What have we learned from basic science studies on idiopathic pulmonary fibrosis? Academic Article
-
What's in a name? That which we call IPF, by any other name would act the same Academic Article
-
Why do patients get idiopathic pulmonary fibrosis? Current concepts in the pathogenesis of pulmonary fibrosis Academic Article
-
miR-92a regulates TGF-β1-induced WISP1 expression in pulmonary fibrosis Academic Article